Home LiteratureArticle Details
PMID: 11110721 Published · ppublish English Editorial Research Support, Non-U.S. Gov't

Age related macular degeneration. New hope for a common problem comes from photodynamic therapy.

BMJ (Clinical research ed.) ·Vol. 321 ·No. 7274 ·2000-12-09 ·Pages 1425-7

Bressler NM

Abstract

暂无摘要

MeSH Terms
Age Factors Humans Macular Degeneration/complications,drug therapy Photochemotherapy/methods Vision Disorders/etiology
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Bressler N M
References (12)
12 references, click to expand
  1. Argon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group.
    Arch Ophthalmol. 1991 Aug;109(8):1109-14 PMID: 1714270
  2. Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Macular Photocoagulation Study Group.
    Arch Ophthalmol. 1993 Sep;111(9):1189-99 PMID: 7689826
  3. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Macular Photocoagulation Study Group.
    Arch Ophthalmol. 1993 Sep;111(9):1200-9 PMID: 7689827
  4. The impact of the macular photocoagulation study results on the treatment of exudative age-related macular degeneration.
    Arch Ophthalmol. 1995 Feb;113(2):185-9 PMID: 7532394
  5. Epidemiology of age-related maculopathy.
    Epidemiol Rev. 1995;17(2):347-60 PMID: 8654516
  6. Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration.
    Ophthalmology. 1999 Sep;106(9):1768-79 PMID: 10485549
  7. Clinical characteristics of choroidal neovascular membranes.
    Arch Ophthalmol. 1987 Feb;105(2):209-13 PMID: 2434067
  8. Krypton Laser photocoagulation for neovascular lesions of age-related macular degeneration.
    Arch Ophthalmol. 1991 May;109(5):614-5 PMID: 1709001
  9. Age-related macular degeneration.
    Surv Ophthalmol. 1988 May-Jun;32(6):375-413 PMID: 2457955
  10. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
    Arch Ophthalmol. 1999 Oct;117(10):1329-45 PMID: 10532441
  11. Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration.
    Surv Ophthalmol. 2000 Nov-Dec;45(3):195-214 PMID: 11094244
  12. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.
    Arch Ophthalmol. 2001 Feb;119(2):198-207 PMID: 11176980
Article Info
Journal
BMJ (Clinical research ed.)
Abbr.
BMJ
ISSN
0959-8138
DOI
10.1136/bmj.321.7274.1425
Published
2000-12-09
Pages
1425-7
Language
English
Region
England
NLM ID
8900488
PMCID
PMC1119155
Subset
IM
Corrections
ErratumIn
-
External Links
PubMed source DOI: 10.1136/bmj.321.7274.1425 PMC Full Text
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2